In addition, Galvao et al. revealed that inhibition of the KLF9–Dusp14 pathway increased axonal growth in vitro and promoted survival and optic nerve regeneration after optic nerve injury in vivo, suggesting modulation of KLF9 as a potential therapeutic approach to reducing axonal damage in neurological diseases. This evidence concerns the gene DUSP14 and nervous system disorder.